Build your base

Alienum phaedrum torquatos nec eu, vis detraxit periculis ex, nihil expetendis in mei. Mei an pericula euripidis, hinc partem ei est.

Solange Corriol-Rohou, MD

New Horizon / Solange Corriol-Rohou, MD

Solange Corriol-Rohou, MD

Sr. Director of Regulatory Affairs & Policy for Europe, AstraZeneca

ABOUT

Solange Corriol-Rohou, a pulmonologist and an immuno-allergist by training, joined AZ R&D in 2004 and is currently Sr. Director of Regulatory Affairs & Policy for Europe. Over the past 20 years, moving from the French Medicines Agency/EMA and a specialist physician position at the Hospital of Versailles to the pharmaceutical industry, she has gained strategic experience in drug development for different therapy areas, such as respiratory, inflammation and oncology. She is currently leading the AZ Paediatric Work Group. Solange, in her role as the chair of the Clinical Development Expert Group at the EFPIA, organized jointly with the EMA several workshops.

Dr. Corriol-Rohou has recently been involved in critical issues, such as Complex Clinical Trial Designs, the use of Digital tools in drug development or the identification of paediatric unmet needs. She also has experience working in IMI projects. Within ICH, as the EFPIA topic leader, she has participated in the revision of the ICHE11 paediatric guideline and is currently keeping the momentum with the ICHE11A Paediatric Extrapolation Guideline to be released in early 2022. She is an active member of the EFGCP Children Medicines Working Party and of TOPRA, with whom she has organised successful workshops.

WEBSITE

https://www.astrazeneca.com/

SESSION

Oct 28 - 9:10 AM ET: Panelist Session 1 – Innovative Techniques Toward Extrapolation and Efficient Drug Development